SpyGlass Pharma, Inc. (SGP)
NASDAQ: SGP · Real-Time Price · USD
22.61
-2.59 (-10.28%)
At close: Mar 27, 2026, 4:00 PM EDT
23.06
+0.45 (1.99%)
After-hours: Mar 27, 2026, 4:19 PM EDT

SpyGlass Pharma Stock Forecast

Stock Price Forecast

The 5 analysts that cover SpyGlass Pharma stock have a consensus rating of "Strong Buy" and an average price target of $45, which forecasts a 99.03% increase in the stock price over the next year. The lowest target is $37 and the highest is $62.

Price Target: $45 (+99.03%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$37$45$42$62
Change+63.64%+99.03%+85.76%+174.21%

Analyst Ratings

The average analyst rating for SpyGlass Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '26
Strong Buy4
Buy1
Hold0
Sell0
Strong Sell0
Total5

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$37
Strong BuyInitiates$37+63.64%Mar 10, 2026
Citigroup
Citigroup
Strong Buy
Initiates
$42
Strong BuyInitiates$42+85.76%Mar 3, 2026
Leerink Partners
Leerink Partners
Buy
Initiates
$42
BuyInitiates$42+85.76%Mar 3, 2026
Jefferies
Jefferies
Strong Buy
Initiates
$62
Strong BuyInitiates$62+174.21%Mar 3, 2026
Stifel
Stifel
Strong Buy
Initiates
$42
Strong BuyInitiates$42+85.76%Mar 3, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
n/a
EPS Next Year
n/a
Fiscal YearFY 2025FY 2026FY 2027
Period EndingDec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
---
Revenue Growth
---
EPS
---
EPS Growth
---
Forward PE
---
No. Analysts
332
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027
High--
Avg--
Low--

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.